Identification of candidate biomarkers and pathways in breast cancer by differential network analysis

被引:0
|
作者
Mendi, Onur [1 ]
Karahoca, Adem [2 ]
机构
[1] Demiroglu Bilim Univ, Dept Bioinformat, Fac Med, Istanbul, Turkey
[2] MEF Univ, Dept Comp Engn, Fac Engn, Istanbul, Turkey
关键词
breast cancer; differential network analysis; bioinformatics; microarray; POOR-PROGNOSIS; EXPRESSION; PROLIFERATION; FOXM1; MECHANISMS; REVEAL; GROWTH; STAT4;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Breast cancer is one of the most malignant cancers in women worldwide. The aim of the present study was to explore the underlying biological mechanisms of breast cancer. For this purpose, we propose a novel framework to reveal mechanisms that drive disease progression in breast cancer by combining prior knowledge in the literature with differential networking methodology. Our integration framework has resulted in the most important genes and interactions by allowing ranking the breast cancer-specific gene network. YY1, SMARCA5, FOXM1, STAT4 and PTTG1 were found to be the most important genes in breast cancer. Functional and pathway enrichment analyses identified numerous pathways that may play a critical role in disease progression. Considering the success of the comparison of the results with the literature, the systemic lupus erythematosus pathway may be a potential target of breast cancer.
引用
收藏
页码:344 / 367
页数:24
相关论文
共 50 条
  • [1] The Identification of Candidate Biomarkers and Pathways in Atherosclerosis by Integrated Bioinformatics Analysis
    Lu, Youwei
    Zhang, Xi
    Hu, Wei
    Yang, Qianhong
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2021, 2021
  • [2] Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis
    Wen, Pushuai
    Chidanguro, Tungamirai
    Shi, Zhuo
    Gu, Huanyu
    Wang, Nan
    Wang, Tongmei
    Li, Yuhong
    Gao, Jing
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 1538 - 1550
  • [3] Ovarian Cancer Differential Interactome and Network Entropy Analysis Reveal New Candidate Biomarkers
    Ayyildiz, Dilara
    Gov, Esra
    Sinha, Raghu
    Arga, Kazim Yalcin
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2017, 21 (05) : 285 - 294
  • [4] Identification of candidate biomarkers correlated with the pathogenesis of breast cancer patients
    Yu, Shiqun
    Wang, Chengman
    Ouyang, Jin
    Luo, Ting
    Zeng, Fanfan
    Zhang, Yu
    Gao, Liyun
    Huang, Shaoxin
    Wang, Xin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [5] Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis
    Chen, Gang
    Yu, Mingwei
    Cao, Jianqiao
    Zhao, Huishan
    Dai, Yuanping
    Cong, Yizi
    Qiao, Guangdong
    BIOENGINEERED, 2021, 12 (01) : 5149 - 5161
  • [6] Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis
    Luo, Yongqi
    Luo, Yangyang
    Chang, Jing
    Xiao, Zhenghui
    Zhou, Bin
    HEREDITAS, 2020, 157 (01)
  • [7] Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis
    Yongqi Luo
    Yangyang Luo
    Jing Chang
    Zhenghui Xiao
    Bin Zhou
    Hereditas, 157
  • [8] Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis
    Liu, Shuyu
    Liu, Xinkui
    Wu, Jiarui
    Zhou, Wei
    Ni, Mengwei
    Meng, Ziqi
    Jia, Shanshan
    Zhang, Jingyuan
    Guo, Siyu
    Lu, Shan
    Li, Yingfei
    MEDICINE, 2020, 99 (49) : E23153
  • [9] Identification of candidate biomarkers and prognostic analysis of recurrence in colorectal cancer
    Xu, Rui
    Feng, Huayun
    Liang, Haojie
    Li, Yaoping
    CANCER BIOMARKERS, 2024, 40 (3-4) : 251 - 262
  • [10] Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer
    Zhou, Qiang
    Ren, Jiangbo
    Hou, Jinxuan
    Wang, Gang
    Ju, Lingao
    Xiao, Yu
    Gong, Yan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (09) : 2383 - 2396